1. REMUS PHARMACEUTICALS L
stock logo

REMUS PHARMACEUTICALS L Share Price

REMUS

₹1,940.00-₹47.90 (-2.41%) TodayLast updated on 16 Jul, 2024 | 13:43 IST
₹1,940.00₹1,995.00
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹1,171 Crs

Open

₹1,990.00

Close

₹1,987.90

Circuit range

₹2,385.45 - ₹1,590.35

Day range

₹1,940.00 - ₹1,995.00

Year range

₹1,785.10 - ₹8,747.00

Volume

2,500

Avg. traded

₹1,981.76

Revenue (12m)

₹45 Crs

REMUS PHARMACEUTICALS LRemus Pharmaceuticals Limited is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredient (API). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, tablet. The therapeutic areas it works include oncology, cardiovascular, anti-diabetic, immune suppressants, anti-biotic, antibacterial, dermatology, central nervous system, and others. Its oncology products include Sorafenib Tablets, Enzalutamide Capsules, Lenalidomide Capsule, and others. Its cardiovascular products include Rivaroxaban Tablets, Ticagrelor Tablets, and others.

REMUS PHARMACEUTICALS L Key indicators

arrow

52 week high

₹8,747.00

52 week low

₹1,785.10

P/E ratio

124.4

P/B ratio

199.77

ROE

66.14%

ROCE

68.82%

Dividend yield

0.1%

Debt/Equity ratio

0.42

EPS

78.37

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

26.93%

Net profit margin

18.88%

ROE

66.14%

ROA

33.77%

ROCE

68.82%

Learn more

REMUS PHARMACEUTICALS L Shareholder returns

arrow

1 day

-1.63%

1 week

-10.08%

1 month

-2.42%

3 months

-65.60%

1 year

-44.03%

3 years

+11.18%

5 years

+11.18%

REMUS PHARMACEUTICALS L Share Price history

arrow
DayOpenCloseDay’s change
Mon, Jul 15 2024
₹2,125.00
₹1,987.90
-0.49%
Fri, Jul 12 2024
₹2,049.90
₹1,997.70
-1.63%
Thu, Jul 11 2024
₹2,063.25
₹2,030.70
-1.58%
Wed, Jul 10 2024
₹2,059.50
₹2,063.25
-0.77%
Tue, Jul 9 2024
₹2,173.00
₹2,079.25
-3.52%
Mon, Jul 8 2024
₹2,230.00
₹2,155.15
-2.99%
Fri, Jul 5 2024
₹2,021.15
₹2,221.60
+9.92%
Thu, Jul 4 2024
₹2,129.00
₹2,021.15
+0.33%

Shareholding info

arrow

Promoters (70.6%)

Mutual Funds (0%)

Retail and other (25.49%)

Foreign institutions-FII (3.25%)

Other domestic institutions (0.67%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Bonus • 3:1

    Ex date 06 Jun 2024

    expand tab
  • Dividend • ₹4/share

    Ex date 02 May 2024

    expand tab
  • Dividend • ₹2/share

    Ex date 27 Oct 2023

    expand tab
  • Dividend • ₹2/share

    Ex date 15 Sep 2023

    expand tab

Learn more

More

Frequently asked questions